Efficacy of recombinant adenovirus-mediated double suicide gene therapy in human keloid fibroblasts

Abstract

Together, the results support the notion that recombinant adenovirus-mediated CDglyTK double suicide gene therapy is effective in destroying keloid fibroblasts and provide a sound scientific rationale for keloid trials in vivo.